Fierce Healthcare November 18, 2022
Dave Muoio

LAS VEGAS—With its focus on profitable exits and increasing presence on the boards of startups and provider organizations alike, it’s little surprise that private equity’s role in healthcare is facing scrutiny.

Policy researchers, nonprofit watchdogs and healthcare industry groups have alleged that PE investments can be tied to strategic decisions that ultimately harm patients or the industry, whether by limiting clinician staffing, price gouging or reducing necessary services in favor of higher margin offerings.

To some extent their cries are being answered by the Biden administration.

Health and Human Services recently released ownership data on roughly 15,000 Medicare-certified nursing homes in a bid to increase transparency and accountability for PE owners trading quality for profits. Alongside a push...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Investments, Provider, Trends
Ilant Health Secures $5.5M for Value-Based Obesity Management & Cardiometabolic Health
Cullinan Nets $280M Investment and Targets CD19 in Lupus
Isospec Analytics Secures $1.9M to Transform Molecular Identification
'Podnosis': Inside Morgan Health's investment strategy and the art of the pitch
Bill promises ‘generational investment’ in senior living and care workforce

Share This Article